A PLP splicing abnormality is associated with an unusual presentation of PMD
Grace M Hobson1, Zhong Huang, Karen Sperle
1Department of Research, Alfred I. duPont Hospital for Children, Wilmington, DE, USA.
Abstract:
We report that a deletion of 19 base pairs (bp) in intron 3 of the proteolipid protein (PLP/DM20) gene causes a neurological disease characterized by mild developmental delay, followed by progressive decline of acquired motor and cognitive milestones. The clinical features are associated with mild delay in myelination demonstrated by magnetic resonance imaging studies and with ongoing demyelination and axonal loss demonstrated by magnetic resonance spectroscopy. We demonstrate that the purine-rich 19bp element regulates PLP-specific splice site selection in transient transfections of chimeric constructs into cultured oligodendrocytes. Runs of 4 and 5 Gs centered in the 19bp element are critical for efficient PLP-specific splicing. The intronic element is sequence specific in oligodendrocytes and is not a repressor of PLP-specific splicing in nonglial cells. These data support the conclusion that deletion of the 19bp purine-rich region in PLP intron 3 causes a reduction in PLP message and protein, which affects myelin stability and axonal integrity.
Insights
A 19 base pair deletion in the proteolipid protein (PLP/DM20) gene causes a neurological disorder. This genetic mutation disrupts myelin development and integrity, leading to progressive motor and cognitive decline.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Proteolipid protein (PLP/DM20) is crucial for myelin formation and maintenance in the central nervous system.
- Genetic mutations in the PLP/DM20 gene are associated with various neurological disorders affecting myelination.
Purpose of the Study:
- To investigate the functional impact of a specific 19 base pair deletion in intron 3 of the PLP/DM20 gene.
- To elucidate the role of this intronic element in regulating PLP/DM20 gene splicing and its contribution to neurological disease.
Main Methods:
- Analysis of a patient with a 19 bp deletion in PLP intron 3.
- Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) to assess myelination and axonal integrity.
- Transient transfection assays using chimeric constructs in cultured oligodendrocytes to study splice site regulation.
Main Results:
- The 19 bp deletion in PLP intron 3 leads to a neurological disease with delayed myelination and progressive demyelination/axonal loss.
- The deleted purine-rich element is essential for regulating PLP-specific splice site selection in oligodendrocytes.
- Specific guanine-rich sequences within the 19 bp element are critical for efficient splicing.
Conclusions:
- Deletion of the 19 bp purine-rich region in PLP intron 3 impairs PLP/DM20 gene expression.
- This impairment results in reduced myelin stability and axonal integrity, causing a progressive neurological disorder.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cytoskeletal Linker Proteins - Plakins
Abnormal Proliferation
Mitral Valve Prolapse I: Introduction


